Literature DB >> 14662519

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.

Rina Bandopadhyay1, Ann E Kingsbury, Mark R Cookson, Andrew R Reid, Ian M Evans, Andrew D Hope, Alan M Pittman, Tammaryn Lashley, Rosa Canet-Aviles, David W Miller, Chris McLendon, Catherine Strand, Andrew J Leonard, Patrick M Abou-Sleiman, Daniel G Healy, Hiroyashi Ariga, Nicholas W Wood, Rohan de Silva, Tamas Revesz, John A Hardy, Andrew J Lees.   

Abstract

Two mutations in the DJ-1 gene on chromosome1p36 have been identified recently to cause early-onset, autosomal recessive Parkinson's disease. As no information is available regarding the distribution of DJ-1 protein in the human brain, in this study we used a monoclonal antibody for DJ-1 to map its distribution in frontal cortex and substantia nigra, regions invariably involved in Parkinson's disease. Western blotting of human frontal cortex showed DJ-1 to be an abundant protein in control, idiopathic Parkinson's disease, cases with clinical and pathological phenotypes of Parkinson's disease with R98Q polymorphism for DJ-1, and in progressive supranuclear palsy (PSP) brains. We also showed that DJ-1 immunoreactivity (IR) was particularly prominent in astrocytes and astrocytic processes in both control and Parkinson's disease frontal cortex, whereas neurons showed light or no DJ-1 IR. Only occasional Lewy bodies (LBs), the pathological hallmarks of Parkinson's disease, showed faint DJ-1 IR, localized to the outer halo. In preclinical studies we showed that DJ-1 is expressed in primary hippocampal and astrocyte cultures of mouse brain. By 2D gel analysis we also showed multiple pI isoforms for DJ-1 ranging between 5.5-6.6 in both control and Parkinson's disease brains, whilst exposure of M17 cells to the oxidizing agent paraquat was manifested as a shift in pI of endogenous DJ-1 towards more acidic isoforms. We conclude that DJ-1 is not an essential component of LBs and Lewy neurites, is expressed mainly by astrocytes in human brain tissue and is sensitive to oxidative stress conditions. These results are consistent with the hypothesis that neuronal-glial interactions are important in the pathophysiology of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662519     DOI: 10.1093/brain/awh054

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  147 in total

1.  The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.

Authors:  Rosa M Canet-Avilés; Mark A Wilson; David W Miller; Rili Ahmad; Chris McLendon; Sourav Bandyopadhyay; Melisa J Baptista; Dagmar Ringe; Gregory A Petsko; Mark R Cookson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-04       Impact factor: 11.205

Review 2.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 3.  The role of cysteine oxidation in DJ-1 function and dysfunction.

Authors:  Mark A Wilson
Journal:  Antioxid Redox Signal       Date:  2011-01-14       Impact factor: 8.401

4.  Keap1-Nrf2 activation in the presence and absence of DJ-1.

Authors:  Li Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Eur J Neurosci       Date:  2010-03-03       Impact factor: 3.386

5.  Parkinson's disease-associated DJ-1 modulates innate immunity signaling in Caenorhabditis elegans.

Authors:  Elena M Cornejo Castro; Jens Waak; Stephanie S Weber; Fabienne C Fiesel; Philipp Oberhettinger; Monika Schütz; Ingo B Autenrieth; Wolfdieter Springer; Philipp J Kahle
Journal:  J Neural Transm (Vienna)       Date:  2010-04-08       Impact factor: 3.575

6.  Absence of DJ-1 causes age-related retinal abnormalities in association with increased oxidative stress.

Authors:  Vera L Bonilha; Brent A Bell; Mary E Rayborn; Ivy S Samuels; Anna King; Joe G Hollyfield; Chengsong Xie; Huaibin Cai
Journal:  Free Radic Biol Med       Date:  2017-01-11       Impact factor: 7.376

Review 7.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

Review 8.  Oxidative damage to macromolecules in human Parkinson disease and the rotenone model.

Authors:  Laurie H Sanders; J Timothy Greenamyre
Journal:  Free Radic Biol Med       Date:  2013-01-15       Impact factor: 7.376

Review 9.  Parkinson's disease and enhanced inflammatory response.

Authors:  Iva Stojkovska; Brandon M Wagner; Brad E Morrison
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

10.  Astrocytic dynamin-like protein 1 regulates neuronal protection against excitotoxicity in Parkinson disease.

Authors:  Jake G Hoekstra; Travis J Cook; Tessandra Stewart; Hayley Mattison; Max T Dreisbach; Zachary S Hoffer; Jing Zhang
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.